Latest Period
Q4 2025
Security Snapshot
Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) Institutional Ownership
CUSIP: 53630X203
13F Institutional Holders and Ownership History from Q1 2021 to Q1 2026
Institutions Reporting
25
Shares (Excl. Options)
1,629,909
Price
$8.03
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- LPCN on Nasdaq
- Shares outstanding
- 5,578,947
- Price per share
- $2.09
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 1,629,909
- Total reported value
- $13,088,240
- % of total 13F portfolios
- 0%
- Share change
- +570,602
- Value change
- +$4,710,434
- Number of holders
- 25
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- LPCN - Lipocine Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 53630X203.
- 25 institutions reported positions in Q4 2025.
- 1 significant owner is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 25 to 5 between Q4 2025 and Q1 2026.
- Reported value moved from $13,088,240 to $2,132,396.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 25 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 53630X203?
CUSIP 53630X203 identifies LPCN - Lipocine Inc. - Common Stock, par value $0.0001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 53630X203:
Significant Owners of Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Squadron Capital Management LLC | 9.5% | +5.6% | $5,549,100 | +$314,100 | 530,000 | +6% | Squadron Master Fund LP | 31 Dec 2025 |
As of 31 Dec 2025, 25 institutional investors reported holding 1,629,909 shares of Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN). This represents 29% of the company’s total 5,578,947 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) together control 29% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Squadron Capital Management LLC | 9.5% | 530,000 | 0% | 1.9% | $4,255,900 |
| DIADEMA PARTNERS LP | 4.7% | 260,939 | 1.2% | $2,095,340 | |
| VANGUARD GROUP INC | 4% | 221,867 | 0% | 0% | $1,781,592 |
| Ikarian Capital, LLC | 3.6% | 199,542 | 0.21% | $1,602,322 | |
| BlackRock, Inc. | 1.6% | 89,272 | 0% | 0% | $716,854 |
| Persistent Asset Partners Ltd | 1.3% | 70,576 | 0.27% | $566,726 | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1% | 62,450 | +2.2% | 0% | $501,544 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.98% | 54,893 | 0.01% | $440,791 | |
| RENAISSANCE TECHNOLOGIES LLC | 0.67% | 37,397 | +3.6% | 0% | $300,298 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.45% | 24,909 | -47% | 0% | $200,019 |
| STATE STREET CORP | 0.33% | 18,626 | 0% | 0% | $149,567 |
| AMERIPRISE FINANCIAL INC | 0.29% | 16,104 | 0% | $129,316 | |
| NORTHERN TRUST CORP | 0.24% | 13,160 | 0% | 0% | $105,675 |
| DIMENSIONAL FUND ADVISORS LP | 0.22% | 12,140 | 0% | 0% | $97,484 |
| JANE STREET GROUP, LLC | 0.19% | 10,574 | 0% | $84,909 | |
| UBS Group AG | 0.1% | 5,603 | +217% | 0% | $44,992 |
| MORGAN STANLEY | 0.01% | 751 | +31% | 0% | $6,031 |
| CALDWELL SUTTER CAPITAL, INC. | 0.01% | 471 | 0% | 0% | $3,782 |
| GROUP ONE TRADING LLC | 0% | 162 | 0% | 0% | $1,301 |
| OSAIC HOLDINGS, INC. | 0% | 118 | -95% | 0% | $947 |
| HighMark Wealth Management LLC | 0% | 100 | 0% | $803 | |
| FMR LLC | 0% | 77 | +31% | 0% | $618 |
| SBI Securities Co., Ltd. | 0% | 67 | 0% | 0% | $538 |
| Tidemark, LLC | 0% | 59 | 0% | 0% | $474 |
| BANK OF AMERICA CORP /DE/ | 0% | 52 | +6.1% | 0% | $417 |
Institutional Holders of Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 266,883 | $2,132,396 | +$2,131,861 | $7.99 | 5 |
| 2025 Q4 | 1,629,909 | $13,088,240 | +$4,710,434 | $8.03 | 25 |
| 2025 Q3 | 529,307 | $1,512,291 | +$2,462 | $2.85 | 21 |
| 2025 Q2 | 528,456 | $1,670,206 | +$34,959 | $3.16 | 18 |
| 2025 Q1 | 517,473 | $1,645,594 | +$97,947 | $3.18 | 19 |
| 2024 Q4 | 486,671 | $2,375,002 | -$289,398 | $4.88 | 17 |
| 2024 Q3 | 544,524 | $2,444,950 | +$9,929 | $4.49 | 18 |
| 2024 Q2 | 531,604 | $4,380,488 | +$476,120 | $8.24 | 18 |
| 2024 Q1 | 473,865 | $2,464,434 | -$16,115 | $5.20 | 17 |
| 2023 Q4 | 483,800 | $1,345,652 | -$46,888 | $2.78 | 18 |
| 2023 Q3 | 499,811 | $1,484,978 | -$7,404 | $2.97 | 20 |
| 2023 Q2 | 477,372 | $2,400,563 | +$2,397,563 | $5.03 | 22 |
| 2021 Q4 | 0 | $0 | -$1,090 | $2.09 | 0 |
| 2021 Q3 | 1,000 | $1,090 | $1.09 | 1 | |
| 2021 Q2 | 1,000 | $1,400 | $1.40 | 1 | |
| 2021 Q1 | 1,000 | $1,510 | +$1,510 | $1.51 | 1 |